This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
Cell Death & Disease Open Access 01 September 2022
-
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
Cell Death & Disease Open Access 26 November 2018
-
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin
Molecular Cytogenetics Open Access 16 January 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Di Ianni M, Baldoni S, Rosati E, Ciurnelli R, Cavalli L, Martelli MF et al. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. Br J Haematol 2009; 146: 689–691.
Sportoletti P, Baldoni S, Cavalli L, Del Papa B, Bonifacio E, Ciurnelli R et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. Br J Haematol 2010; 151: 404–406.
Rosati E, Sabatini R, Rampino G, Tabilio A, Di Ianni M, Fettucciari K et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 2009; 113: 856–865.
Sportoletti P, Baldoni S, Del Papa B, Cantaffa R, Ciurnelli R, Aureli P et al. A novel NOTCH1 PEST domain mutation in a case of chronic lymphocytic leukemia. Leuk Lymphoma 2012; 54: 1780–1782.
Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101–105.
Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389–1401.
Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497–2506.
Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, Lawrence MS et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2013; 152: 714–726.
Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269–271.
Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012; 119: 521–529.
Kluck MJ, Ashworth T, Wang H, Knoechel B, Mason EF, Morgan EA et al. Gauging NOTCH1 activation in cancer using immunohistochemistry. PLoS One 2013; 8: e67306.
Villamor N, Conde L, Martínez-Trillos A, Cazorla M, Navarro A, Beà S et al. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia 2013; 27: 1100–1106.
Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood 2012; 119: 329–331.
Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 2012; 97: 437–441.
López C, Delgado J, Costa D, Conde L, Ghita G, Villamor N et al. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. Cancer 2012; 51: 881–889.
Oscier DG, Rose-Zerilli MJ, Winkelmann N, Gonzalez de Castro D, Gomez B, Forster J et al. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 2013; 121: 468–475.
Weissmann S, Roller A, Jeromin S, Hernández M, Abáigar M, Hernández-Rivas JM et al. Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients. Leukemia 2013; e-pub ahead of print 17 July 2013 doi:10.1038/leu.2013.218.
Acknowledgements
We would like to thank Dr Geraldine Anne Boyd for her help. This work was supported by ‘Associazione Umbra Leucemie e Linfomi’, Perugia Italy, by ‘Associazione Italiana Leucemie, Linfomi e Mieloma’, L’Aquila Section, L’Aquila, Italy and by grant from Progetti di Ricerca di Interesse Nazionale-PRIN (2010-2011—prot. 2010MCLPLB_005; to ER). LR is a Leukemia and Lymphoma Society Scholar in Clinical Research.
Author contributions
PS analyzed and interpreted the data, conducted the statistical analyses and wrote the manuscript; SB developed the AR-PCR assay, performed the experimental work and contributed in writing the manuscript; BDP conducted part of the statistical analyses and contributed in writing the manuscript; PA and ED performed the molecular diagnostic assays; LR conducted part of the statistical analyses; SP, VA and ADT contributed patient samples and data; ER and PM contributed to interpretation of biological data; MDI and FF led the project, supervised the study and wrote the manuscript. All authors critically reviewed the final manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of financial interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Sportoletti, P., Baldoni, S., Del Papa, B. et al. A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia. Leukemia 28, 436–439 (2014). https://doi.org/10.1038/leu.2013.289
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.289
This article is cited by
-
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL
Cell Death & Disease (2022)
-
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin
Molecular Cytogenetics (2018)
-
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation
Cell Death & Disease (2018)
-
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation
Leukemia (2016)
-
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia
Leukemia (2016)